Researchers use CareDx solutions to monitor first successful heart xenotransplantation

CareDx Inc. announced its non-invasive organ transplant surveillance solutions were used to monitor postoperative graft health in the first successful heart xenotransplantation.

According to the press release, surgeons from the University of Maryland School of Medicine (UMSOM) are using versions of two Care-Dx surveillance solutions to monitor the genetically modified pig heart they transplanted into a patient on Jan. 7, 2022. Read more.